- Home
- FIHL vs IMCR Comparison
FIHL vs IMCR Comparison
Compare FIHL & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FIHL
- IMCR
- Stock Information
- Founded
- FIHL 2014
- IMCR 2008
- Country
- FIHL Bermuda
- IMCR United Kingdom
- Employees
- FIHL N/A
- IMCR N/A
- Industry
- FIHL
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FIHL
- IMCR Health Care
- Exchange
- FIHL Nasdaq
- IMCR Nasdaq
- Market Cap
- FIHL 2.1B
- IMCR 1.7B
- IPO Year
- FIHL 2023
- IMCR 2021
- Fundamental
- Price
- FIHL $17.43
- IMCR $32.93
- Analyst Decision
- FIHL Buy
- IMCR Buy
- Analyst Count
- FIHL 9
- IMCR 14
- Target Price
- FIHL $20.50
- IMCR $74.75
- AVG Volume (30 Days)
- FIHL 302.1K
- IMCR 267.8K
- Earning Date
- FIHL 11-12-2024
- IMCR 11-05-2024
- Dividend Yield
- FIHL 2.30%
- IMCR N/A
- EPS Growth
- FIHL N/A
- IMCR N/A
- EPS
- FIHL 3.82
- IMCR N/A
- Revenue
- FIHL $2,151,300,000.00
- IMCR $280,914,000.00
- Revenue This Year
- FIHL N/A
- IMCR $25.60
- Revenue Next Year
- FIHL $13.62
- IMCR $10.63
- P/E Ratio
- FIHL $4.55
- IMCR N/A
- Revenue Growth
- FIHL N/A
- IMCR 27.95
- 52 Week Low
- FIHL $11.55
- IMCR $29.72
- 52 Week High
- FIHL $20.53
- IMCR $76.98
- Technical
- Relative Strength Index (RSI)
- FIHL 46.22
- IMCR 52.76
- Support Level
- FIHL $17.24
- IMCR $31.10
- Resistance Level
- FIHL $17.74
- IMCR $35.47
- Average True Range (ATR)
- FIHL 0.34
- IMCR 1.49
- MACD
- FIHL -0.04
- IMCR 0.17
- Stochastic Oscillator
- FIHL 28.79
- IMCR 51.98
About FIHL Fidelis Insurance Holdings Limited
Fidelis Insurance Holdings Ltd is a global (re)insurance company. It classify the business into three underwriting segments, namely Bespoke, Specialty and Reinsurance. Specialty primarily comprises property D&F, energy, marine and aviation lines. Bespoke primarily comprises credit and political risk and other tailored solutions for clients including transactional liabilities and credit insurance. Reinsurance primarily comprises property reinsurance.
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a late-stage biotechnology company engaged in the development of a novel class of TCR bispecific immunotherapies for the treatment of cancer, infectious and autoimmune diseases. Its geographical segments are the United Kingdom and the United States, of which the majority of its revenue comes from the United States.